2) Endometrial receptivity
子宫内膜容受性
1.
Three-dimensional ultrasonic assessment of endometrial receptivity;
三维超声评价子宫内膜容受性
2.
Effects of Jiantai Liquid on Endometrial Receptivity During Implantation in Model Mice;
健胎液对模型小鼠着床期子宫内膜容受性的影响
3.
Advances in study on relation letween integrins and endometrial receptivity;
整合素与子宫内膜容受性关系的研究进展
3) Endometrium receptivity
子宫内膜容受性
1.
Study of endometrium receptivity improved with Kunbao granule;
坤宝颗粒改善子宫内膜容受性的研究
2.
Objective: To investigate the mechanism of the effects of endome-triosis on humam endometrium receptivity and provide the knowledgefor treating endometriosis-induced infertility, C-fos protein and integrinβ_3 subunit were detected in eutopic endometrium during implantation win-dow.
目的：通过测定子宫内膜异位症(EM)患者窗口期在位子宫内膜c-fos蛋白、整合素β_3亚单位的表达，以探讨子宫内膜异位症对子宫内膜容受性影响的可能机制，并为子宫内膜异位症所致不孕的治疗提供理论依据。
4) uterine receptivity
子宫内膜容受性
1.
Effect of Uterine Receptivity Based on Different Ovarian Stimulation Protocols of Mice s;
不同方案超排卵对小鼠子宫内膜容受性影响的研究
2.
Purpose To investigate the function of Galectin-3 in the establishment of human uterine receptivity.
目的探讨半乳凝素-3(Galectin-3)在人类子宫内膜容受性形成中的作用。
3.
Objective To initially evaluate the effect of viagra on improving the uterine receptivity.
目的初步探讨万艾可改善子宫内膜容受性的作用。
5) endomelrium area
子宫内膜面积
1.
Objective To observe the effect of Bushenhuoluofang on follicular number, endomelrium area and endocrine of androgen sterilized rats (ASR).
目的观察补肾活络中药用药前后雄激素致不孕大鼠(ASR)卵巢卵泡数、子宫内膜面积和内分泌的变化。
6) Endometrium
[英][,endəu'mi:triəm] [美][,ɛndo'mitrɪəm]
子宫内膜
1.
Analysis of Normal Endometrium with MRS of Childbearing Women in Different Menstrual Cycle;
育龄妇女不同月经周期子宫内膜MRS初步分析
2.
Expression of phosphatase and tensin homolog deleted on chromosome ten in mouse endometrium and its effect during blastocyst implantation;
PTEN在早孕小鼠子宫内膜的表达及其对胚泡着床的影响(英文)
3.
The Expression of Osteopontin in Endometrium and Correlated Diseases;
骨桥蛋白在子宫内膜及其相关病变中的表达
补充资料：子宫内膜癌腔内放射治疗
子宫内膜癌腔内放射治疗
子宫内膜癌腔内放疗有：①传统方法，使用治疗子宫颈癌的治疗容器，如宫腔管及阴道容器，(容器有：斯德哥尔摩盒式、巴黎弓形、曼彻斯特卵圆形、北京型等)。其缺点是子宫角部受量不足；②Heyman倡导宫腔填充法，将含有镭或其他同位素的金属小囊填满于子宫腔内，使宫腔各壁均能得到高剂量照射，可使单纯放疗效果由30%～40%增至60%以上；③腔内后装放射治疗。剂量：现在采用高剂量率及中剂量率，摒弃低剂量率。高剂量率：Ⅰ期：A点(位于子宫旁三角区内，代表宫旁正常组织受量)总剂量36～40Gy，F点(位于宫腔放射源的顶端旁开子宫中轴2cm，代表肿瘤部受量)总剂量40～45Gy。腔内治疗分5～6次进行，每周1次，每次剂量大致相同。Ⅱ期～Ⅲ期：A点及F点总剂量均为45～50Gy，腔内治疗分6～7次，每周1次，每次剂量大致相同。中剂量率：Ⅰ期：A点总剂量率45～50Gy，F点总剂量50～55Gy，腔内治疗6～8次，每周1次，每次剂量基本相似，Ⅱ～Ⅲ期：A点及F点剂量均为55～60Gy，腔内治疗7～8次，每周1次，每次剂量大致相同。腔内照射多用137Cs、60Co等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条